# A Study of CT-388 in Otherwise Healthy Overweight and Obese Adults and Patients With Type 2 Diabetes Mellitus

> **NCT04838405** · PHASE1 · COMPLETED · sponsor: **Carmot Therapeutics, Inc.** · enrollment: 129 (actual)

## Conditions studied

- Diabetes

## Interventions

- **DRUG:** CT-388
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04838405
- **Lead sponsor:** Carmot Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-29
- **Primary completion:** 2024-06-18
- **Final completion:** 2024-08-02
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2025-10-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04838405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04838405, "A Study of CT-388 in Otherwise Healthy Overweight and Obese Adults and Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04838405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*